Harvard Bioscience (HBIO) Misses Q4 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Harvard Bioscience, Inc. (NASDAQ: HBIO) | Delayed: 8.61 -0.06 (0.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.67 | 52 Week High | $3.90 | |||
| Open | $8.85 | 52 Week Low | $2.25 | |||
| Day High | $8.85 | P/E | N/A | |||
| Day Low | $8.57 | EPS | $-0.03 | |||
| Volume | 10,309 | |||||
